Emily Melton

Emily is drawn to disruptive ideas and technologies that have the potential to radically change healthcare markets. Her portfolio includes BetterUp, Brightline, Calibrate, Clearing, Elation Health, HumanFirst, Imagen, Livongo (NASDAQ: LVGO acquired by Teladoc Health), Ooda Health (acquired by Cedar), Redfin (NASDAQ: RDFN), Shift (NASDAQ: SFT), Tia, Transcarent, Verge Genomics, Vineti, Vital, Viz, and Wellframe (acquired by HealthEdge). In 2019, Forbes recognized Emily on the Midas Brink List as an investor destined for success based on her reputation and momentum in the industry. Emily is an active founding member of All Raise, a non-profit dedicated to improving access for women and others to start and invest in companies. She also serves on the board of the National Venture Capital Association (NVCA). Emily is a Stanford grad with a BA in political philosophy with honors and an MBA.